Home
English
English
简体中文
Sign In
Help Desk
Journals
Advanced Search
BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Featured Articles
Journals
Submit a Manuscript
Articles Published Processes
Keyword:
Ribavirin
Page 1 of 2 ( 52 items )
<<
1
2
>>
1
Glecaprevir/pibrentasvir + sofosbuvir for post-liver transplant recurrent hepatitis C virus treatment
2/24/2023 1:35:50 PM |
Browse: 606 |
Download: 1333
2
Effectiveness and safety of generic and brand direct acting antivirals for the treatment of chronic hepatitis C
12/2/2022 12:50:19 PM |
Browse: 644 |
Download: 2001
3
Controversies’ clarification regarding ribavirin efficacy in measles and coronaviruses: Comprehensive therapeutic approach strictly tailored to COVID-19 disease stages
6/24/2021 7:26:32 AM |
Browse: 691 |
Download: 2024
4
Sofosbuvir plus ribavirin is tolerable and effective even in elderly patients 75-years-old and over
9/21/2020 4:02:08 PM |
Browse: 915 |
Download: 2601
5
Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature
5/6/2019 10:43:10 AM |
Browse: 1325 |
Download: 2646
6
Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus
4/4/2018 1:15:45 PM |
Browse: 1468 |
Download: 2900
7
Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals
12/5/2017 1:55:00 AM |
Browse: 1421 |
Download: 2670
8
Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review
5/17/2017 6:29:40 AM |
Browse: 1694 |
Download: 3033
9
Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection
2/6/2017 9:08:00 AM |
Browse: 1332 |
Download: 2944
10
Miliary tuberculosis infection during hepatitis C treatment with sofosbuvir and ledipasvir plus ribavirin
1/22/2017 8:28:00 AM |
Browse: 1765 |
Download: 2979
11
Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country
11/18/2016 3:13:00 PM |
Browse: 1351 |
Download: 2971
12
Retrospective study of the associations between hepatitis C virus infection and metabolic factors
10/25/2016 8:46:00 AM |
Browse: 1928 |
Download: 3264
13
Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma
10/12/2016 2:18:00 PM |
Browse: 1594 |
Download: 2065
14
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience
8/3/2016 8:11:00 AM |
Browse: 1933 |
Download: 3308
15
Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus
3/2/2016 1:35:00 PM |
Browse: 2047 |
Download: 3846
16
Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma
2/25/2016 7:04:00 PM |
Browse: 1420 |
Download: 2759
17
Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia
2/22/2016 3:38:00 PM |
Browse: 1622 |
Download: 3259
18
Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-/ribavirin therapy
1/23/2016 5:08:00 PM |
Browse: 1688 |
Download: 2438
19
Analysis of peripheral blood dendritic cells as a non-invasive tool in the follow-up of patients with chronic hepatitis C
1/20/2016 5:04:00 PM |
Browse: 1405 |
Download: 2408
20
Ribavirin: Past, present and future
1/15/2016 9:49:00 AM |
Browse: 1616 |
Download: 2280
21
Hepatitis E virus infection in the liver transplant recipients: Clinical presentation and management
1/15/2016 9:49:00 AM |
Browse: 1564 |
Download: 2028
22
Hepatitis C genotype 4: The past, present, and future
12/4/2015 3:24:00 PM |
Browse: 2298 |
Download: 3090
23
Telaprevir- and boceprevir-based tritherapies in real practice for F3-F4 pretreated hepatitis C virus patients
12/2/2015 12:20:00 PM |
Browse: 2032 |
Download: 2369
24
Hepatitis C in hemodialysis patients
12/2/2015 12:01:00 PM |
Browse: 1610 |
Download: 2056
25
Alpha-fetoprotein and des-gamma-carboxy-prothrombin at twenty-four weeks after interferon-based therapy predict hepatocellular carcinoma development
11/27/2015 5:17:00 PM |
Browse: 1668 |
Download: 3186
26
Hepatitis E virus infection: Epidemiology and treatment implications
11/12/2015 5:09:00 PM |
Browse: 1492 |
Download: 2694
27
Ribavirin contributes to eradicate hepatitis C virus through polarization of T helper 1/2 cell balance into T helper 1 dominance
11/9/2015 6:35:00 PM |
Browse: 1608 |
Download: 2219
28
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens
6/29/2015 4:40:00 PM |
Browse: 1571 |
Download: 3009
29
Hepatitis C: New challenges in liver transplantation
5/20/2015 5:01:00 PM |
Browse: 1441 |
Download: 2890
30
Natural interferon-beta treatment for patients with chronic hepatitis C in Japan
5/19/2015 5:28:00 PM |
Browse: 1590 |
Download: 2302
31
Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study
5/18/2015 5:02:00 PM |
Browse: 1683 |
Download: 2127
32
Relevance of low viral load in haemodialysed patients with chronic hepatitis C virus infection
5/18/2015 5:02:00 PM |
Browse: 1364 |
Download: 2358
33
Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control
3/30/2015 5:46:00 PM |
Browse: 1689 |
Download: 2726
34
Current status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6
3/13/2015 3:29:00 PM |
Browse: 1617 |
Download: 2289
35
Chronic hepatitis C genotype 1 treatment roadmap for resource constrained settings
2/11/2015 5:56:00 PM |
Browse: 1792 |
Download: 2519
36
Retreatment with peginterferon and ribavirin in chronic hepatitis C
2/11/2015 5:56:00 PM |
Browse: 1479 |
Download: 1950
37
Study of pruritus in chronic hepatitis C patients
12/20/2014 9:24:00 PM |
Browse: 1434 |
Download: 2328
38
Ribavirin induced hemolysis: A novel mechanism of action against chronic hepatitis C virus infection
12/5/2014 11:43:00 AM |
Browse: 1528 |
Download: 2216
39
New treatments for chronic hepatitis C: an overview for paediatricians
12/5/2014 11:43:00 AM |
Browse: 1761 |
Download: 2620
40
Telaprevir/boceprevir era: From bench to bed and back
9/16/2014 8:07:00 PM |
Browse: 1744 |
Download: 2119
41
Pre-treatment role of inosine triphosphate pyrophosphatase polymorphism for predicting anemia in Egyptian hepatitis C virus patients
9/16/2014 4:56:00 PM |
Browse: 1460 |
Download: 1342
42
Factors associated with early virological response to peginterferon-α-2a/ribavirin in chronic hepatitis C
9/16/2014 3:23:00 PM |
Browse: 1374 |
Download: 1207
43
Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation
9/15/2014 8:53:00 PM |
Browse: 1540 |
Download: 1701
44
Hepatitis C, stigma and cure
9/12/2014 8:41:00 PM |
Browse: 1708 |
Download: 1623
45
Hepatitis C genotype 6: A concise review and response-guided therapy proposal
9/10/2014 4:40:00 PM |
Browse: 1498 |
Download: 1618
46
Association of ITPA polymorphism with outcomes of peginterferon-α plus ribavirin combination therapy
9/5/2014 2:19:00 PM |
Browse: 1330 |
Download: 1613
47
Challenges in managing hepatitis C virus infection in cancer patients
9/1/2014 2:51:00 PM |
Browse: 1333 |
Download: 1333
48
Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection
9/1/2014 2:51:00 PM |
Browse: 1496 |
Download: 1858
49
Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian children
8/28/2014 5:50:00 PM |
Browse: 1771 |
Download: 1776
50
Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
8/26/2014 3:10:00 PM |
Browse: 1497 |
Download: 2167
Page 1 of 2 ( 52 items )
<<
1
2
>>
Write to the Help Desk
All content on this site:
Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.